Erol R. Akdamar - Feb 17, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Group President
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Feb 17, 2023
Transactions value $
-$817,432
Form type
4
Date filed
2/22/2023, 06:55 PM
Previous filing
Feb 6, 2023
Next filing
May 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Award $0 +9.3K +23.37% $0.00 49.1K Feb 17, 2023 Direct F1
transaction HCA Common Stock Tax liability -$817K -3.11K -6.33% $262.84 46K Feb 17, 2023 Direct
holding HCA Common Stock 60K Feb 17, 2023 By LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 29, 2020, the reporting person was granted 4,650 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.